MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Org 27569

CAS No. : 868273-06-7

MCE 国际站：Org 27569

产品活性：Org 27569 是有效的 CB1 receptor 别构调节剂，既能增加激动剂与 CB1 结合，又能抑制激动剂诱导的 CB1 信号通路。

研究领域：GPCR/G Protein  |  Neuronal Signaling

作用靶点：Cannabinoid Receptor

In Vitro: Org 27569 enhances agonist (CP55940) binding, promotes agonist binding to CB1 yet inhibits agonist-induced G protein activation and blocks the agonist-induced conformational changes in TM6. Org 27569 inhibits agonist-induced TM6 movement in CB1 detected by a fluorescent probe on site 342. Org 27569 produces a significant, but saturable, increase in the level of specific [³H]CP 55,940 binding. Org 27569 (1 μM) inhibits electrically evoked contractions of the mouse vas deferens with the pEC₅₀ and E_max being 8.66±0.11 and 77% (95% confidence limits, 70.6-82.7), respectively. In hCB1R cells, Org 27569 (1 and 10 μM) behaves as a weak inverse agonist producing a small but significant decrease in basal [³⁵S]GTPγS binding. Org 27569 is less effective as an inhibitor of WIN55212-mediated inhibition of forskolin-stimulated cAMP production. Org 27569 induces a small but significant level of ERK1/2 phosphorylation with an E_max of 19% and pEC₅₀ value of 8.55±0.99.

In Vivo: ORG 27569 (3.2 and 5.6 mg/kg, i.p.) significantly attenuates cocaine associated cue-induced reinstatement, cocaine priming-induced reinstatement, methamphetamine associated cue-induced reinstatement and methamphetamine priming-induced reinstatement in rat. Org27569 (30 mg/kg, i.p.) produces CB1-independent hypophagic effects and does not affect the discriminative stimulus effects of anandamide (AEA). Org27569 (100 μg intracerebroventricularly) does not affect the pharmacologic effects of systemically administered CP55,940 compared with vehicle.

相关产品：Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Neuronal Signaling Compound Library  |  Pain-Related Compound Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  CB2R probe 1  |  CB2R/FAAH modulator-3  |  Cannabinodiol  |  CB1 inverse agonist 2  |  CB2 receptor antagonist 1  |  Taranabant racemate  |  CB1 antagonist 2  |  LEI-101  |  Auriculasin  |  CB1R Allosteric modulator 2  |  NESS 0327  |  Pregnenolone monosulfate sodium  |  CB2R-IN-1  |  Bay 59-3074  |  CB1 antagonist 1  |  β-Caryophyllene  |  (R)-SLV 319  |  Ajulemic acid  |  Nimacimab  |  (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide  |  L759633  |  Docosatetraenylethanolamide  |  Noladin ether  |  JTE-907  |  BML-190  |  O1918  |  Tocrifluor 1117  |  BAY 38-7271  |  TM38837

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物  |  寡核苷酸  |  抗体  |  点击化学

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides  |  Antibodies  |  Click Chemistry

货号: HY-13288

品牌介绍:
•   MCE (MedChemExpress) 拥有200 多种全球独家化合物库，我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物；
•   50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领；
•   产品种类涵盖各种重组蛋白，多肽，常用试剂盒 ，更有 PROTAC、ADC 等特色产品，广泛应用于新药研发、生命科学等科研项目；
•   提供虚拟筛选，离子通道筛选，代谢组学分析检测分析，药物筛选等专业技术服务；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
•   专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。